Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.

BMC pediatrics - 14 Nov 2019

Pan Gang, Zhang Linmei, Zhou Shuizhen

Abstract excerpt

BACKGROUND: The objective of this study was to summarize clinical features and PRRT2 mutations of paediatric paroxysmal kinesigenic dyskinesia (PKD) patients and observe the tolerability and effects of morning draughts of oxcarbazepine. METHODS: Twenty patients diagnosed with PKD at Children's Hospital of Fudan University between January 2011 and December 2015 were enrolled. These patients' medical records were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Anticonvulsants
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnostic Errors

Share to Dose-Response Relationship, Drug

Share to Dystonia

Share to Epilepsy

Share to Nerve Tissue Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 31722684
DOI: 10.1186/s12887-019-1798-7
PMCID: PMC6854699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.PMID 31722684Read ↗

Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.Semantic proximity Read ↗

[Clinical features and PRRT2 gene mutation in paroxysmal kinesigenic dyskinesia].Semantic proximity Read ↗

Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patients.Semantic proximity Read ↗

[Clinical manifestations and genetic diagnosis of paroxysmal kinesigenic dyskinesia].Semantic proximity Read ↗

Lacosamide for children with paroxysmal kinesigenic dyskinesia.Semantic proximity Read ↗

Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia.Semantic proximity Read ↗

PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.Semantic proximity Read ↗

Clinico-genetic comparisons of paroxysmal kinesigenic dyskinesia patients with and without PRRT2 mutations.Semantic proximity Read ↗

Clinical characteristics and PRRT2 gene mutation analysis of sporadic patients with paroxysmal kinesigenic dyskinesia in China.Semantic proximity Read ↗

Paroxysmal kinesigenic dyskinesia: clinical report of 10 cases from three pedigrees with literature review.Semantic proximity Read ↗

PRRT2 mutation screening in patients with paroxysmal kinesigenic dyskinesia from Southwest China.Semantic proximity Read ↗

Paroxysmal movement disorders: An update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.